BioSpace News Archive

Initiated VANISH Phase 3 program of oral ibrexafungerp in acute VVC; top-line data expected in 1H 2020 with potential NDA filing in 2H 2020

Owlstone Medical (or the “Company”), a global diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Cancer Research UK, today announces the clinical launch of the PAN Cancer trial for Early Detection of Cancer in Breath1, with the first patients now being recruited for the 1,500 patient study.

DURECT Corporation invites interested parties to listen to a corporate update conference call that will be broadcast live over the internet on Monday, January 7, 2019 at 8:00 am Eastern Time (5:00 am Pacific Time).

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company’s president and CEO, is scheduled to present a company overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 11:00am PT in San Francisco, CA.

Valens GroWorks Corp. is pleased to announce that they have hired Everett Knight as Executive Vice President, Strategy & Investments.

Reports clinical data updates with MultiTAA T cells in lymphoma, multiple myeloma and acute lymphoblastic leukemia

Healthcare technology company EnableComp LLC announced today that it has added two new product lines including Motor Vehicle Accident (MVA) and Veterans Administration (VA) claims processing to become a full complex claims revenue cycle management company.

Validates the Company’s Commitment to Health, Safety, Security, and Environmental Performance

Aquestive Therapeutics, Inc. today announced the appointment of Gary H. Slatko as SVP, Chief Medical Officer (CMO). Dr. Slatko will lead clinical and medical affairs for the company, and is reporting to CEO Keith J. Kendall, effective January 2, 2019.

Employer Direct Healthcare is excited to announce its partnership with Coca-Cola Consolidated